Should dexamethasone be used as an adjunct in the treatment of peritonsillar abscess, and what is the appropriate dosing regimen for adults and children?

Dexamethasone for Peritonsillar Abscess

Yes, dexamethasone should be used as adjunctive therapy in peritonsillar abscess treatment, as it provides significant early symptom relief without increasing complications.

Recommendation

Administer a single intravenous dose of dexamethasone (10 mg for adults, 0.15 mg/kg for children) at the time of abscess drainage and antibiotic initiation. This approach reduces pain, fever, and trismus within the first 24 hours, though benefits diminish by 48 hours 1, 2.

Evidence Supporting Use

The strongest evidence comes from multiple randomized controlled trials and systematic reviews demonstrating:

• Pain reduction: Significantly lower pain scores at 24 hours (1.4 vs 5.1 on pain scale, P = .009) 1
• Faster symptom resolution: Improved body temperature, trismus, and dysphagia in the first 24 hours 2
• Earlier discharge: Higher discharge rates within 5 days post-treatment 2
• No adverse effects: No serious side effects reported across all trials 1, 3, 2

A meta-analysis of 153 patients across three RCTs confirmed statistically significant improvements in pain-related parameters, body temperature, and clinical course when steroids were added to standard antibiotic therapy 2.

Dosing Regimen

Adults

• 10 mg dexamethasone IV as a single dose 1, 4
• Administer at time of drainage procedure
• Combine with IV antibiotics (typically clindamycin 600-900 mg or ampicillin-sulbactam)

Children

• 0.15 mg/kg dexamethasone IV (based on tonsillectomy guidelines) 5
• Maximum single dose: 10 mg
• Same timing principles apply

Clinical Algorithm

1. Confirm diagnosis via needle aspiration (yields pus in peritonsillar abscess; note that intratonsillar abscesses have only 15% aspiration success rate) 6

2. Immediate treatment:

   • Drain abscess (aspiration or incision)
   • Give dexamethasone 10 mg IV
   • Start IV antibiotics (clindamycin 600 mg or co-amoxiclav 1.2 g) 4

3. Expect maximal benefit at 24 hours: Pain relief, reduced fever, improved mouth opening

4. Reassess at 24-48 hours: Benefits plateau after 24 hours; by 48 hours, differences between steroid and non-steroid groups become non-significant 1

Important Caveats

The benefit is short-lived: While dexamethasone provides meaningful symptom relief in the first 24 hours, this advantage disappears by 48 hours 1. This is a symptomatic treatment, not a disease-modifying intervention.

Timing matters: Administer dexamethasone at the time of drainage and antibiotic initiation for optimal effect. The evidence specifically supports single-dose administration, not prolonged courses 7.

Outpatient management is feasible: With this protocol (drainage + antibiotics + dexamethasone), 91% of patients can be successfully managed as outpatients with high satisfaction rates 4.

Contraindications to Consider

While the trials reported no adverse events, use clinical judgment to avoid dexamethasone in:

• Uncontrolled diabetes (single dose poses minimal risk)
• Active gastrointestinal bleeding
• Suspected deep neck space extension requiring surgical exploration (though one pediatric study showed dexamethasone reduced surgical drainage rates from 53% to 36%, P = .043) 8

Bottom line: The evidence consistently supports single-dose dexamethasone as safe and effective adjunctive therapy that accelerates early symptom resolution in peritonsillar abscess, though it does not alter the fundamental disease course or need for definitive drainage and antibiotics.